Skip to main content
Top

16-04-2024 | Erectile Dysfunction | Urology - Original Paper

Association between atherogenic indexes and erectile dysfunction: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001–2004

Authors: Lange Guo, Yukui Nan, Lizhong Yao

Published in: International Urology and Nephrology

Login to get access

Abstract

Purpose

Elevated blood lipids are considered a risk factor for atherosclerosis, which can lead to erectile dysfunction. This study aimed to explore the relationship between the atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli’s risk index-I (CRI-I), Castelli’s risk index-II (CRI-II), and erectile dysfunction.

Methods

Based on the National Health and Nutrition Examination Survey (NHANES) data from 2001–2004, multivariable-adjusted logistic regression models were used to evaluate the association between AIP, AC, CRI-I, and CRI-II with ED. Smooth curve fitting was employed to assess the linear association.

Results

A total of 1806 male participants with complete data were enrolled in the study. In Model 1, those in the highest tertile of AIP had a 49% increased risk of ED compared to the lowest tertile (OR 1.49; 95% CI 1.15–1.91 p = 0.0021). After adjusting for the variables of age, race, education, body mass index, and poverty income ratio (PIR), significant positive correlations were found between ED and AIP, with each 1-unit increase in AIP associated with a 65% increase in the risk of developing ED (OR 1.65; 95% CI 1.03–2.64 p = 0.0361).

Conclusions

AIP is positively associated with the development of ED in US adults. More prospective cohort studies are needed to confirm the link between AIP and ED.
Literature
1.
go back to reference NIH Consensus Conference. Impotence. NIH (1993) Consensus development panel on impotence. JAMA 270(1):83–90CrossRef NIH Consensus Conference. Impotence. NIH (1993) Consensus development panel on impotence. JAMA 270(1):83–90CrossRef
4.
go back to reference Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation 139(25):e1082–e1143. https://doi.org/10.1161/CIR.0000000000000625CrossRefPubMed Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation 139(25):e1082–e1143. https://​doi.​org/​10.​1161/​CIR.​0000000000000625​CrossRefPubMed
7.
go back to reference Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ et al (2009) Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 55(1):35–41CrossRefPubMed Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ et al (2009) Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 55(1):35–41CrossRefPubMed
12.
go back to reference Akin F, Altun I, Ayca B, Kose N, Altun I (2022) Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults. Bosn J Basic Med Sci 22(6):1025–1032CrossRefPubMedPubMedCentral Akin F, Altun I, Ayca B, Kose N, Altun I (2022) Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults. Bosn J Basic Med Sci 22(6):1025–1032CrossRefPubMedPubMedCentral
13.
go back to reference Rao K, Du GH, Yang WM (2005) Correlation between abnormal serum lipid and erectile dysfunction. Zhonghua Nan Ke Xue 11(2):112–115PubMed Rao K, Du GH, Yang WM (2005) Correlation between abnormal serum lipid and erectile dysfunction. Zhonghua Nan Ke Xue 11(2):112–115PubMed
18.
go back to reference Mackness B, Mackness M (2012) The antioxidant properties of high-density lipoproteins in atherosclerosis. Panminerva Med 54(2):83–90PubMed Mackness B, Mackness M (2012) The antioxidant properties of high-density lipoproteins in atherosclerosis. Panminerva Med 54(2):83–90PubMed
Metadata
Title
Association between atherogenic indexes and erectile dysfunction: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001–2004
Authors
Lange Guo
Yukui Nan
Lizhong Yao
Publication date
16-04-2024
Publisher
Springer Netherlands
Published in
International Urology and Nephrology
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-024-04050-4
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.